People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Upkara Inc. | — | Biotechnology | Series A | $24.3M | $18.0M | 2024 |
| Emit Imaging, Inc. | — | Biotechnology | Series A | $13.5M | $33.5M | 2023 |
Jack U. Hoppin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jack U. Hoppin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William U. Parfet | 2 | 5 |
| Jack Hoppin | 1 | 2 |
| Christian Lackas | 1 | 2 |
| Pravansu S. Mohanty | 1 | 2 |
| William Parfet | 1 | 2 |
| Richard U. Troyer | 1 | 1 |
| Craig U. Manson | 1 | 1 |
| Carl S. Le Souef | 1 | 1 |
| Alan S. Turfe | 1 | 1 |
| Steve S. Annear | 1 | 1 |
| Matthew Silva | 1 | 1 |
| Christian U. Lackas | 1 | 1 |
| Paul U. Meister | 1 | 1 |
| Matthew U. Cobbett | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.